The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Clinical Intervention Awards, 2007Helicobacter Pylori Eradication and Motor Fluctuations in Parkinson's Disease
Objective/Rationale:
Helicobacter pylori is a common bacterial infection often associated with disorders of the gastrointestinal tract. Treatment of H. pylori in patients with Parkinson’s disease has... -
Clinical Intervention Awards, 2007NH004 Films for Sialorrhea in PD Patients (2007)
Objective/Rationale:
The goal of the research is to advance the clinical development of NH004 for the control of sialorrhea (excessive drooling or uncontrolled salivation). NH004 is a dissolving film... -
Clinical Intervention Awards, 2007The role of striatal serotonergic terminals in L-dopa induced-dyskinesia in PD patients: An in vivo PET study
Objective Rationale:
In this project the team will explore a possible mechanism responsible for a common complication of long-term L-dopa treatment in Parkinson’s disease (PD), L-dopa induced... -
Rapid Response Innovation Awards, 2007Using Drosophila models of Parkinson’s disease to study the neuroprotective potential of tobacco and coffee
Objective/Rationale:
Tobacco and coffee users develop Parkinson’s disease at a significantly lower frequency than the general public. While there are several possible interpretations of these findings... -
Rapid Response Innovation Awards, 2007Ghrelin Protects Nigral Dopamine Neurons
Objective/Rationale:
Our preliminary findings indicate that the gut hormone, ghrelin, has a major impact on the functionality and protection of nigrostriatal dopamine neurons. We, therefore, will test... -
Rapid Response Innovation Awards, 2007Feasibility of Intranasal Delivery of GDNF for Parkinson's Disease
Objective/Rationale:
Glial cell line-derived neurotrophic factor (GDNF) is a small protein that potently promotes the survival of many types of neurons. The therapeutic potential of GDNF for Parkinson...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.